Medicare Enrolled
Dr. Manhal Naoumi, M.D.
Family Medicine · Warren, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Naoumi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naoumi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Naoumi
Dr. Manhal Naoumi is a family medicine specialist in Warren, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Naoumi performed 5,524 Medicare services across 2,689 unique beneficiaries.
Between the years covered by Open Payments, Dr. Naoumi received a total of $6,458 from 40 pharmaceutical and/or device companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Naoumi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in MI
$6,458 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,524
Medicare services
Top 1% in MI for family medicine
2,689
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~276 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,339 | $64 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
671 | $89 | $181 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
427 | $137 | $420 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
419 | $95 | $186 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
328 | $61 | $114 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
234 | $93 | $250 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
215 | $102 | $199 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
151 | $64 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
122 | $122 | $208 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
93 | $10 | $30 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
64 | $8 | $8 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
56 | $24 | $55 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
54 | $3 | $7 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
49 | $130 | $226 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
40 | $33 | $35 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
40 | $11 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
37 | $25 | $25 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
29 | $40 | $150 |
| Injection, methylprednisolone acetate, 40 mg | 29 | $6 | $15 |
| Annual depression screening | 27 | $18 | $40 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
20 | $37 | $60 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
18 | $43 | $100 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
14 | $30 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $116 | $222 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
12 | $166 | $275 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
11 | $25 | $40 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
11 | $25 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,458
Total received (2018-2024)
Avg $923/year across 7 years
Top 6% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
410
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,458 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,120
2023
$887
2022
$866
2021
$1,239
2020
$735
2019
$796
2018
$816
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Exact Sciences Corporation
$144
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$109
Abbott Laboratories
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$83
Amgen Inc.
$76
PFIZER INC.
$76
Xeris Pharmaceuticals, Inc.
$70
Novo Nordisk Inc
$67
Dexcom, Inc.
$66
AstraZeneca Pharmaceuticals LP
$54
Lilly USA, LLC
$53
GlaxoSmithKline, LLC.
$44
ABBVIE INC.
$41
Novartis Pharmaceuticals Corporation
$38
SHIELD THERAPEUTICS INC
$33
Alkermes, Inc.
$29
Astellas Pharma US Inc
$24
Merck Sharp & Dohme LLC
$15
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 30.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$848
PFIZER INC.
$687
Boehringer Ingelheim Pharmaceuticals, Inc.
$645
Amgen Inc.
$538
Novo Nordisk Inc
$507
Lilly USA, LLC
$413
Novartis Pharmaceuticals Corporation
$352
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$296
Exact Sciences Corporation
$239
Amarin Pharma Inc.
$215
Abbott Laboratories
$173
AstraZeneca Pharmaceuticals LP
$162
Astellas Pharma US Inc
$139
ABBVIE INC.
$138
Takeda Pharmaceuticals U.S.A., Inc.
$123
E.R. Squibb & Sons, L.L.C.
$111
GlaxoSmithKline, LLC.
$98
Xeris Pharmaceuticals, Inc.
$93
Allergan, Inc.
$81
Shield Therapeutics Inc
$70
Dexcom, Inc.
$66
RedHill Biopharma Inc.
$53
Biohaven Pharmaceuticals, Inc.
$44
AbbVie Inc.
$42
SHIELD THERAPEUTICS INC
$33
DEXCOM, INC.
$33
Bayer HealthCare Pharmaceuticals Inc.
$32
Ultragenyx Pharmaceutical Inc.
$29
Eisai Inc.
$29
Alkermes, Inc.
$29
Smith+Nephew, Inc.
$19
Bausch Health US, LLC
$18
ABIOMED
$16
Merck Sharp & Dohme LLC
$15
Biohaven Pharmaceutical Holding Company Ltd.
$15
Bayer Healthcare Pharmaceuticals Inc.
$13
Concordia Pharmaceuticals Inc.
$12
Allergan Inc.
$12
Merck Sharp & Dohme Corporation
$11
Genentech USA, Inc.
$11
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ARISTADA · Aemcolo · Aimovig · Amitiza · BAQSIMI · BASAGLAR · BREO · BREZTRI · BREZTRI AEROSPHERE · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DIFICID · DONNATAL · Dayvigo · Dexcom G6 Transmitter · Dexilant · ELIQUIS · ENTRESTO · EVENITY · EVUSHELD · FARXIGA · FASENRA · FIASP · FLUMIST QUADRIVALENT · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · INVOKANA · Impella · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LYRICA · MIGRANAL · MOUNJARO · MYRBETRIQ · NURTEC ODT · Otezla · Ozempic · PAXLOVID · Prolia · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Santyl · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Talicia · Trintellix · UBRELVY · VIBERZI · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · Xofluza · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in MI.
Geographic Context
Family medicine physicians within 10 mi
1,851
Per 100K population
210.9
County median income
$76,399
Nearest hospital
THE BEHAVIORAL CENTER OF MICHIGAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Naoumi is a clinical cardiology specialist, with above-average Medicare volume (top 1% in MI), with low-engagement industry engagement in the top 6% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Naoumi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Naoumi performed 2,339 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Naoumi receive payments from pharmaceutical companies?
Yes. Dr. Naoumi received a total of $6,458 from 40 companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naoumi's costs compare to other family medicine physicians in Warren?
Dr. Naoumi's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naoumi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Warren
Browse family medicine physicians in Warren ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in MI
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in MI
Which MI family medicine physicians receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology